Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.315 USD | -0.06% | +1.61% | +1.94% |
12:42pm | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
14/05 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.94% | 31.68M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+48.49% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Dare Bioscience Awarded $385,000 Grant to Develop Therapy for Idiopathic Preterm Birth